https://de.marketscreener.com/kurs/aktie/TAKEDA-PHARMACEUTICAL-COM-6491073/news/Takeda-Pharmaceuticals-U-S-A-Inc-gibt-die-Zulassung-von-Adzynma-Intravenose-Injektion-1500-Apad-46287966/?utm_source=telegram&utm_medium=social&utm_campaign=share